ADCT
ADC Therapeutics SA
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report0 of 7 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
ADC Therapeutics SA
1.52
+0.03 · +2.01%
post 1.52 0.00%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Nantahala Capital ManagementNantahala | $13.2M | 15.24% | +120.21% | |
| 2 | Redmile GroupRedmile | $12.3M | 14.25% | −25.49% | |
| 3 | TCG Crossover ManagementTCG Crossover | $12.2M | 14.08% | 0.00% | |
| 4 | Prosight ManagementProsight | $8.4M | 9.67% | −5.73% | |
| 5 | BlackRockBlackRockindex-like | $7.5M | 8.68% | +12.31% | |
| 6 | Point72 Asset ManagementPoint72 | $3.9M | 4.54% | +7.83% | |
| 7 | Morgan StanleyMorgan Stanley | $3.3M | 3.77% | −19.97% | |
| 8 | Millennium ManagementMillennium | $3.3M | 3.77% | −6.29% | |
| 9 | Citadel AdvisorsCitadel | $2.2M | 2.54% | +413.69% | |
| 10 | Goldman Sachs GroupGoldman Sachs | $2.0M | 2.37% | +15.81% | |
| 11 | State StreetState Streetindex-like | $1.8M | 2.08% | +7.61% | |
| 12 | Geode Capital ManagementGeodeindex-like | $1.5M | 1.79% | +20.09% | |
| 13 | Bank of AmericaBank of America | $1.4M | 1.59% | −2.78% | |
| 14 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $959,888 | 1.11% | −13.18% | |
| 15 | Two Sigma InvestmentsTwo Sigma | $827,553 | 0.96% | +15.78% | |
| 16 | Blue Owl Capital HoldingsBlue Owl Capital | $784,918 | 0.91% | 0.00% | |
| 17 | D. E. ShawD. E. Shaw | $769,672 | 0.89% | +195.80% | |
| 18 | Opaleye ManagementOpaleye | $749,000 | 0.87% | new | |
| 19 | AQR Capital ManagementAQR | $704,193 | 0.81% | +176.95% | |
| 20 | BNP Paribas ArbitrageBNP Paribas Arbitrage | $698,548 | 0.81% | −24.13% | |
| 21 | Northern TrustNorthern Trustindex-like | $635,607 | 0.73% | +7.57% | |
| 22 | Platinum Investment ManagementPlatinum | $622,322 | 0.72% | −41.30% | |
| 23 | Panagora Asset ManagementPanagora | $612,913 | 0.71% | −17.14% | |
| 24 | UBS GroupUBS | $556,714 | 0.64% | +13.38% | |
| 25 | Schroder Investment Management GroupSchroder | $431,345 | 0.50% | 0.00% |
113 managers report $86.6M of ADC Therapeutics on form 13F for the quarter ended Jun 30 '26. 11 of them hold 80% of it; Nantahala is largest at 15.24%.
Expected move
No implied move.
No implied move.
No implied move.